Skip to main content

How early to start: what do observational data suggest?

National and international guidelines on antiretroviral therapy for HIV infection recently changed to recommend earlier treatment, following the publication during 2009 of two collaborative analyses of HIV cohort studies [1, 2]. These studies used different methodologies, and reached different conclusions about the benefits of very early treatment. I will describe their methods, and possible reasons for differences in their results.

References

  1. Kitahata MM, Gange SJ, Abraham AG, NAACCORD Investigators, et al: Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009, 360 (18): 1815-1826. 10.1056/NEJMoa0807252.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  2. When To Start Consortium: Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009, 373 (9672): 1352-1363. 10.1016/S0140-6736(09)60612-7.

    PubMed Central  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Sterne, J. How early to start: what do observational data suggest?. JIAS 13, O34 (2010). https://doi.org/10.1186/1758-2652-13-S4-O34

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1758-2652-13-S4-O34

Keywords

  • Public Health
  • Infectious Disease
  • Cohort Study
  • Early Treatment
  • Observational Data